<h1>Study Structure</h1>
<p>Launched as a pilot study in 2009, the LRRK2 Cohort Consortium assembles and studies groups of people with and without PD who carry mutations in the LRRK2 gene. Today, it is comprised of multiple sites in nine countries.</p>
<h2>Study Documents</h2>
<ul class="noOrangeLi">
<li><a href="/files/LRRK2_Cohort_Consortium_Biologics_Manual _US.pdf" class="docLink" target="_blank">Biologics Manual (US)</a> | laboratory biologics manual used by the North American sites</li>
<li><a href="/files/LRRK2_Cohort_Consortium_Biologics_Manual_Europe.pdf" class="docLink" target="_blank">Biologics Manual (Europe)</a> | laboratory biologics manual used by the European sites</li>
<li><a href="/files/LRRK2C_All_in_One.pdf" class="docLink" target="_blank">Case Report Form</a> | list of variables collected </li>
<li><a href="/files/LRRK2%20Cohort%20Consortium%20Publication%20Policy%20(FINAL).pdf" class="docLink" target="_blank">Publication Policy</a> | policies required for any public presentations or manuscripts related to the LRRK2 Cohort Consortium resources</li>
<li><a href="/files/Data%20Dictionary%2001July2013.pdf" class="docLink" target="_blank">Data Dictionary</a> | explanation of variables and caveats; MJFF brought together existing cohorts to form the LRRK2 Cohort Consortium. Although standardized protocols were adopted by the participating sites, individual Case Report Forms were used creating some differences in collection methods. The Data Dictionary provides a guide to these variances.</li>
<li><a href="/files/MJFF%20LRRK2%20Cohort%20Consortium%20Biospecimen%20Use%20Policy%20Final%20(May%2030,%202013).pdf" class="docLink" target="_blank">Biospecimen Use Policy</a> | policies related to use of Consortium biospecimens</li>
<li><a href="/files/MJFF%20LRRK2%20Cohort%20Consortium%20Data%20Use%20Agreement%20Final%20(May%2030,%202013).pdf" class="docLink" target="_blank">Data Use Agreement</a> | policies related to use of Consortium data</li>
</ul>
<p class="h-divider"> </p>
<h2>Consortium Sites</h2>
<table class="studyDesignTable">
<tbody>
<tr><th>Study Sites</th><th>Principal Investigators</th></tr>
<tr>
<td>Ashkenazi Jewish Consortium</td>
<td>
<p><span class="bold">Susan Bressman</span> <br /> (Beth Israel Medical Center, New York, NY)</p>
<p><span class="bold">Nir Giladi</span> <br /> (Tel-Aviv Sourasky Medical Center Tel Aviv, Israel)</p>
<p><span class="bold">Karen Marder</span> <br /> (Columbia University Medical Center, New York, NY)</p>
</td>
</tr>
<tr>
<td>ASAP Study</td>
<td>
<p><span class="bold">Jose Felix Marti Masso</span> <br /> (Hospital Donostia, San Sebastian, Spain)</p>
<p><span class="bold">Eduardo Tolosa</span> <br /> (Hospital Clinic de Barcelona, Barcelona, Spain)</p>
</td>
</tr>
<tr>
<td></td>
<td>
<p><span class="bold">Jan Aasly</span> <br /> (University Hospital - Norwegian University of Science and Technology, Trondheim, Norway)</p>
</td>
</tr>
<tr>
<td></td>
<td>
<p><span class="bold">Daniela Berg and Thomas Gasser</span> <br /> (University of Tuebingen, Germany)</p>
</td>
</tr>
<tr>
<td></td>
<td>
<p><span class="bold">Alexis Brice and Jean-Christopher Corvol</span> <br /> (Hôpital de la Pitié-Salpétrière, Paris, France)</p>
</td>
</tr>
<tr>
<td></td>
<td>
<p><span class="bold">Piu (Bill) Chan</span> <br /> (Xuanwu Hospital of Capital Medical University, Beijing, China)</p>
</td>
</tr>
<tr>
<td></td>
<td>
<p><span class="bold">Emily Drabant</span> <br /> (23andMe, Inc. Mountain View, CA)</p>
</td>
</tr>
<tr>
<td>PROGENI Study</td>
<td>
<p><span class="bold">Tatiana Foroud</span> <br /> (Indiana University School of Medicine, Indianapolis, IN)</p>
</td>
</tr>
<tr>
<td></td>
<td>
<p><span class="bold">Faycal Hentati and Matthew Farrer</span> <br /> (National Institute of Neurology Tunis, Tunisia)</p>
</td>
</tr>
<tr>
<td></td>
<td>
<p><span class="bold">Connie Maras and Anthony Lang</span> <br /> (Toronto Western Hospital, Toronto, Canada)</p>
</td>
</tr>
<tr>
<td></td>
<td>
<p><span class="bold">Birgitt Schuele</span> <br /> (The Parkinson's Institute, Sunnyvale, CA)</p>
</td>
</tr>
<tr>
<td>Data Repository Core</td>
<td>The Clinical Trials Coordinating Center at the University of Rochester is responsible for the collection, tracking and performance of quality control of the clinical data.</td>
</tr>
<tr>
<td>Biorepository Core</td>
<td>The biorepositories, including <span>Coriell Institute for Medical Research</span>, BioRep, Tel-Aviv Sourasky Medical Center, and Beijing Human Genetics Center, receive, store, and distribute biospecimens collected throughout the course of the study.</td>
</tr>
<tr>
<td>Clinical Coordinator</td>
<td>Matt Read (PRN, Basingstoke, Hampshire, United Kingdom)</td>
</tr>
</tbody>
</table>
